Pfizer and Merck to Collaborate on Study Evaluating Novel Anti-Cancer Combination Regimen
WHITEHOUSE STATION, N.J. – Pfizer Inc. (NYSE:PFE) and Merck Co. Inc. (NYSE: MRK), known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the …